
Closing Bell Overtime: 1/13/26
Closing Bell
00:00
Dexcom turnaround strategy with new CEO
Jake Leach outlines Dexcom's growth plan, CGM adoption, coverage expansion, and interaction with GLP-1 therapies.
Play episode from 35:34
Transcript

Jake Leach outlines Dexcom's growth plan, CGM adoption, coverage expansion, and interaction with GLP-1 therapies.